FBR Capital Starts SXC Health Solutions (SXCI) at Outperform; HIT and PBM: A Match Made in Heaven
Tweet
Share
E-mailGet Alerts SXCI Hot Sheet
Price: $93.02 --0%
Rating Summary:
11 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
11 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
FBR Capital initiates coverage on SXC Health Solutions (NASDAQ: SXCI) with an Outperform.
FBR analyst says, "We are initiating coverage of SXCI with an Outperform rating and a $69 price target, representing 24% potential upside from the current share price. We base our investment thesis on SXC’s ability to win market share as it takes advantage of overarching pharmacy benefit management (PBM) sector trends, such as the increased availability of generic drugs and growth of the specialty pharmaceuticals business. While SXC is expected to grow rapidly over the next two years, we view the company as having the potential to be a disruptive force to the “big three” PBMs in the larger-client market. SXC’s technology platform, which it also sells to other PBMs, is a valuable part of the company’s strategy to continue winning contracts with both middle-market and larger clients."
For more ratings news on SXC Health Solutions click here and for the rating history of SXC Health Solutions click here.
Shares of SXC Health Solutions closed at $55.36 yesterday.
FBR analyst says, "We are initiating coverage of SXCI with an Outperform rating and a $69 price target, representing 24% potential upside from the current share price. We base our investment thesis on SXC’s ability to win market share as it takes advantage of overarching pharmacy benefit management (PBM) sector trends, such as the increased availability of generic drugs and growth of the specialty pharmaceuticals business. While SXC is expected to grow rapidly over the next two years, we view the company as having the potential to be a disruptive force to the “big three” PBMs in the larger-client market. SXC’s technology platform, which it also sells to other PBMs, is a valuable part of the company’s strategy to continue winning contracts with both middle-market and larger clients."
For more ratings news on SXC Health Solutions click here and for the rating history of SXC Health Solutions click here.
Shares of SXC Health Solutions closed at $55.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Starts Luxshare Precision (2475:HK) at Buy
- Craig-Hallum Starts Horizon Quantum (HQ) at Buy
- Citi Starts Federal Signal (FSS) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
